Search results
Author(s):
Yaacoub Chahine
,
Matthew J Magoon
,
Bahetihazi Maidu
,
et al
Added:
11 months ago
Author(s):
Tze-Fan Chao
,
Chern-En Chiang
,
Shih-Ann Chen
Added:
3 years ago
Burden of Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, accounting for approximately one-third of hospitalisations for cardiac rhythm disturbances.1 Between 1980 and 2000, the age-adjusted incidence of AF significantly increased from 3.04 to 3.68 per 1,000 person-years in the US.2 The prevalence of AF was lower among African Americans…
View more
Author(s):
Ajit Yoganathan
,
Fotis Sotiropoulos
Added:
3 years ago
Background
Since the first successful implantation of a prosthetic heart valve four decades ago, over 50 different designs have been developed including both mechanical and bioprosthetic valves. Today, with over 200,000 implants worldwide each year, the most widely implanted design is the mechanical bileaflet prosthesis. Several other mechanical valves are currently available and many of them…
View more
Author(s):
Farhan Shahid
,
Gregory YH Lip
Added:
3 years ago
Atrial fibrillation (AF) and heart failure (HF) are global epidemics that began more than a century ago, and their association with an ageing general population has brought about an increase in cardiovascular morbidity and rising healthcare costs.1,2 More than 50 % of patients with permanent AF have a concurrent diagnosis of HF and this proportion is expected to rise.3 It is well established that…
View more
Author(s):
Eunice NC Onwordi
,
Amr Gamal
,
Azfar Zaman
Added:
3 years ago
Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. Despite the use of optimal medical therapy and revascularisation there remains a significant risk of vascular events. Registry data indicates a persistent risk even in patients who are event free in the first year following ACS, with as many as 1 in 5 patients suffering a vascular event in the subsequent 3 years.1
The…
View more
Author(s):
Christian Mahnkopf
,
Younghoon Kwon
,
Nazem Akoum
Added:
2 years ago
Author(s):
Gordon Lowe
,
John Yarnell
Added:
3 years ago
Clinicians and pathologists have long recognised the role of the haemostatic system in acute coronary and cerebral thrombosis, and anti-platelet, anticoagulant and fibrinolytic therapies are well established in clinical practice. Pathologists have suggested for several decades that 'hypercoagulability' contributes to the development of atheroma,1 plaque formation and rupture.2,3 Pioneering…
View more
Author(s):
Bob Kloner
,
Kiyotake Ishikawa
Added:
3 years ago
Author(s):
Maki Komiyama
,
Koji Hasegawa
Added:
3 years ago
Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has generated a pandemic that has heavily affected the global population, with more than 5.2 million infected and more than 337,000 deaths worldwide recorded between the end of 2019 and 24 May 2020.1 In the absence of vaccines or specific targeted treatments, strategies to…
View more
Author(s):
Braghadheeswar Thyagarajan
,
Ankur Kalra
,
Alefiyah Rajabali
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM), with a reported prevalence of AF in HCM of about 25 %.1 Patients with AF in HCM tend to be more symptomatic and have an increased stroke risk compared with patients without HCM.2 While the occurrence and treatment of (symptomatic) AF in HCM have been extensively studied, there is little data…
View more